1	Nuclear	nuclear	_	_	_	_	_	_	_
2	factor-kappa	factor-kappa	_	_	_	_	_	_	_
3	B	B	_	_	_	_	_	_	_
4	activity	activity	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	from	from	_	_	_	_	_	_	_
9	patients	patient	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	rheumatic	rheumatic	_	_	_	_	_	_	_
12	diseases	disease	_	_	_	_	_	_	_
13	:	:	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	preliminary	preliminary	_	_	_	_	_	_	_
16	report	report	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	OBJECTIVE	objective	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	The	the	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B/Rel	B/Rel	_	_	_	_	_	_	_
6	family	family	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	factors	factor	_	_	_	_	_	_	_
10	regulates	regulate	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	many	many	_	_	_	_	_	_	_
15	genes	gene	_	_	_	_	_	_	_
16	involved	involve	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	immune	immune	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	inflammatory	inflammatory	_	_	_	_	_	_	_
22	response	response	_	_	_	_	_	_	_
23	at	at	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	transcriptional	transcriptional	_	_	_	_	_	_	_
26	level	level	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	aim	aim	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	study	study	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	determine	determine	_	_	_	_	_	_	_
9	whether	whether	_	_	_	_	_	_	_
10	distinctive	distinctive	_	_	_	_	_	_	_
11	patterns	pattern	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	NF-kappa	NF-kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	are	be	_	_	_	_	_	_	_
17	seen	see	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	different	different	_	_	_	_	_	_	_
20	forms	form	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	joint	joint	_	_	_	_	_	_	_
23	disease	disease	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	The	the	_	_	_	_	_	_	_
4	DNA	dna	_	_	_	_	_	_	_
5	binding	binding	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	these	these	_	_	_	_	_	_	_
9	nucleoproteins	nucleoprotein	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	examined	examine	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	purified	purify	_	_	_	_	_	_	_
14	synovial	synovial	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	peripheral	peripheral	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	from	from	_	_	_	_	_	_	_
20	patients	patient	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	various	various	_	_	_	_	_	_	_
23	chronic	chronic	_	_	_	_	_	_	_
24	rheumatic	rheumatic	_	_	_	_	_	_	_
25	diseases	disease	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	12	12	_	_	_	_	_	_	_
28	:	:	_	_	_	_	_	_	_
29	four	four	_	_	_	_	_	_	_
30	with	with	_	_	_	_	_	_	_
31	rheumatoid	rheumatoid	_	_	_	_	_	_	_
32	arthritis	arthritis	_	_	_	_	_	_	_
33	;	;	_	_	_	_	_	_	_
34	five	five	_	_	_	_	_	_	_
35	with	with	_	_	_	_	_	_	_
36	spondyloarthropathies	spondyloarthropathy	_	_	_	_	_	_	_
37	;	;	_	_	_	_	_	_	_
38	and	and	_	_	_	_	_	_	_
39	three	three	_	_	_	_	_	_	_
40	with	with	_	_	_	_	_	_	_
41	osteoarthritis	osteoarthritis	_	_	_	_	_	_	_
42	)	)	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
4	mobility	mobility	_	_	_	_	_	_	_
5	shift	shift	_	_	_	_	_	_	_
6	assays	assay	_	_	_	_	_	_	_
7	disclosed	disclose	_	_	_	_	_	_	_
8	two	two	_	_	_	_	_	_	_
9	specific	specific	_	_	_	_	_	_	_
10	complexes	complex	_	_	_	_	_	_	_
11	bound	bind	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	NF-kappa	NF-kappa	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	specific	specific	_	_	_	_	_	_	_
17	32P-labelled	32p-labelled	_	_	_	_	_	_	_
18	oligonucleotide	oligonucleotide	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	nucleoproteins	nucleoprotein	_	_	_	_	_	_	_
21	extracted	extract	_	_	_	_	_	_	_
22	from	from	_	_	_	_	_	_	_
23	purified	purify	_	_	_	_	_	_	_
24	T	t	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	isolated	isolate	_	_	_	_	_	_	_
27	from	from	_	_	_	_	_	_	_
28	synovial	synovial	_	_	_	_	_	_	_
29	fluid	fluid	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	peripheral	peripheral	_	_	_	_	_	_	_
32	blood	blood	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	patients	patient	_	_	_	_	_	_	_
35	with	with	_	_	_	_	_	_	_
36	rheumatoid	rheumatoid	_	_	_	_	_	_	_
37	arthritis	arthritis	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	complexes	complex	_	_	_	_	_	_	_
3	consisted	consist	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	p50/p50	p50/p50	_	_	_	_	_	_	_
6	homodimers	homodimer	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	p50/p65	p50/p65	_	_	_	_	_	_	_
9	heterodimers	heterodimer	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	Increased	increase	_	_	_	_	_	_	_
2	NF-kappa	NF-kappa	_	_	_	_	_	_	_
3	B	B	_	_	_	_	_	_	_
4	binding	bind	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	DNA	DNA	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	synovial	synovial	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	observed	observe	_	_	_	_	_	_	_
13	relative	relative	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	peripheral	peripheral	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	non-rheumatoid	non-rheumatoid	_	_	_	_	_	_	_
3	arthritis	arthritis	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	binding	binding	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	synovial	synovial	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	exclusively	exclusively	_	_	_	_	_	_	_
15	mediated	mediate	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	p50/p50	p50/p50	_	_	_	_	_	_	_
18	homodimers	homodimer	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	CONCLUSION	conclusion	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Overall	overall	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	results	result	_	_	_	_	_	_	_
7	suggest	suggest	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	NF-kappa	NF-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	may	may	_	_	_	_	_	_	_
12	play	play	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	central	central	_	_	_	_	_	_	_
15	part	part	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	infiltrating	infiltrate	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	chronic	chronic	_	_	_	_	_	_	_
25	rheumatoid	rheumatoid	_	_	_	_	_	_	_
26	arthritis	arthritis	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	nuclear	nuclear	_	_	_	_	_	_	_
6	factor	factor	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	qualitatively	qualitatively	_	_	_	_	_	_	_
9	different	different	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	rheumatoid	rheumatoid	_	_	_	_	_	_	_
12	synovial	synovial	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	other	other	_	_	_	_	_	_	_
19	forms	form	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	non-rheumatoid	non-rheumatoid	_	_	_	_	_	_	_
22	arthritis	arthritis	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	for	for	_	_	_	_	_	_	_
25	example	example	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	osteoarthritis	osteoarthritis	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	spondyloarthropathies	spondyloarthropathy	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

